(Q27001549)

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

6 January 2025

1 reference

2

David J. Glass

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22795476

6 January 2025

author name string

Kenneth C.H. Fearon

1

1 reference

Kenneth C. H. Fearon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22795476

6 January 2025

Denis C. Guttridge

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22795476

6 January 2025

language of work or name

1 reference

8 August 2012

1 reference

12 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22795476

full work available at URL

6 January 2025

http://www.cell.com/article/S1550413112002483/pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A22795476

https://api.elsevier.com/content/article/PII:S1550413112002483?httpAccept=text/xml

6 January 2025

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

https://api.elsevier.com/content/article/PII:S1550413112002483?httpAccept=text/plain

6 January 2025

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

6 January 2025

1 reference

16

1 reference

issue

2

1 reference

page(s)

153-66

1 reference

Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Mechanisms for skeletal muscle insulin resistance in patients with pancreatic ductal adenocarcinoma

6 January 2025

2

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Cutaneous castleman's disease responds to anti interleukin-6 treatment

6 January 2025

3

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders

6 January 2025

4

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation

6 January 2025

5

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice

6 January 2025

6

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

MAFbx/Atrogin-1 expression is a poor index of muscle proteolysis

6 January 2025

7

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Changes in myostatin signaling in non-weight-losing cancer patients

6 January 2025

8

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1.

6 January 2025

9

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload

6 January 2025

10

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Interleukin-6 and cachexia in ApcMin/+ mice

6 January 2025

11

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis

6 January 2025

12

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer

6 January 2025

13

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Effect of cancer cachexia on triacylglycerol/fatty acid substrate cycling in white adipose tissue

6 January 2025

14

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Animal models of the cancer anorexia–cachexia syndrome

6 January 2025

15

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia

6 January 2025

16

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy

6 January 2025

17

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Cachectin and tumour necrosis factor as two sides of the same biological coin

6 January 2025

18

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia.

6 January 2025

19

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice

6 January 2025

20

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise

6 January 2025

21

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Identification of ubiquitin ligases required for skeletal muscle atrophy

6 January 2025

22

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

6 January 2025

23

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Functional improvement of dystrophic muscle by myostatin blockade.

6 January 2025

24

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia

6 January 2025

25

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The RING finger domain: a recent example of a sequence-structure family

6 January 2025

26

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients

6 January 2025

27

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

IKKbeta/NF-kappaB activation causes severe muscle wasting in mice

6 January 2025

29

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Nitrogen movement between host and tumor in mice inoculated with Ehrlich ascitic tumor cells

6 January 2025

30

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

6 January 2025

31

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Exploring autonomic nervous system dysfunction in patients with cancer cachexia: a pilot study

6 January 2025

32

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Combined treatment with GH, insulin, and indomethacin alleviates cancer cachexia in a mouse model

6 January 2025

33

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle

6 January 2025

34

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation

6 January 2025

35

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Compartmental body composition of cancer patients by measurement of total body nitrogen, potassium, and water

6 January 2025

36

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans

6 January 2025

37

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines

6 January 2025

38

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle

6 January 2025

39

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Adipose tissue pathways involved in weight loss of cancer cachexia

6 January 2025

40

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

PKM2 tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect.

6 January 2025

41

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia

6 January 2025

42

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Cancer cachexia is associated with the IL10 -1082 gene promoter polymorphism in patients with gastroesophageal malignancy.

6 January 2025

43

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Clinical outcomes and contributors to weight loss in a cancer cachexia clinic

6 January 2025

45

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Association Between Serum Cortisol and Testosterone Levels, Opioid Therapy, and Symptom Distress in Patients with Advanced Cancer

6 January 2025

46

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

6 January 2025

47

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

6 January 2025

48

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Increased urinary excretion of cortisol and catecholami-NES in malnourished cancer patients

6 January 2025

49

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding

6 January 2025

50

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Protein synthesis in muscle measured in vivo in cachectic patients with cancer

6 January 2025

51

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer

6 January 2025

52

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Cancer cachexia: developing multimodal therapy for a multidimensional problem

6 January 2025

53

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response

6 January 2025

55

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Definition and classification of cancer cachexia: an international consensus

6 January 2025

56

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care--correlations with food intake, metabolism, exercise capacity, and hormones

6 January 2025

57

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle

6 January 2025

58

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies

6 January 2025

59

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Signaling pathways perturbing muscle mass

6 January 2025

60

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Glucose metabolism in cancer. Evidence that demethylation events play a role in activating type II hexokinase gene expression

6 January 2025

61

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Activins and activin antagonists in the prostate and prostate cancer

6 January 2025

62

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

6 January 2025

63

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Hypothalamic mechanisms in cachexia

6 January 2025

64

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia

6 January 2025

65

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy.

6 January 2025

66

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The regulation and functions of activin and follistatin in inflammation and immunity.

6 January 2025

67

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Tissue components of weight loss in cancer patients. A new method of study and preliminary observations

6 January 2025

68

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Altered glucose metabolism in metastatic carcinoma

6 January 2025

69

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Lactate metabolism in patients with metastatic colorectal cancer

6 January 2025

70

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Mechanisms of TNF-alpha-induced insulin resistance

6 January 2025

71

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression

6 January 2025

72

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Elevated energy expenditure in cancer patients with solid tumours.

6 January 2025

73

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Voluntary running, skeletal muscle gene expression, and signaling inversely regulated by orchidectomy and testosterone replacement

6 January 2025

74

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Molecular analysis of lipid-depleting factor in a colon-26-inoculated cancer cachexia model

6 January 2025

75

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice

6 January 2025

76

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).

6 January 2025

78

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer

6 January 2025

79

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control

6 January 2025

80

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss.

6 January 2025

81

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun NH2-terminal kinase, Notch, and Akt signaling pathways

6 January 2025

82

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Hindlimb casting decreases muscle mass in part by proteasome-dependent proteolysis but independent of protein synthesis

6 January 2025

83

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy

6 January 2025

84

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy

6 January 2025

85

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Neural control of the anorexia-cachexia syndrome.

6 January 2025

86

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression

6 January 2025

87

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Regulation of muscle growth by multiple ligands signaling through activin type II receptors

6 January 2025

88

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Activin A circulating levels in patients with bone metastasis from breast or prostate cancer.

6 January 2025

89

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle

6 January 2025

90

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Activin signaling: effects on body composition and mitochondrial energy metabolism

6 January 2025

91

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands

6 January 2025

92

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres

6 January 2025

93

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice

6 January 2025

94

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins

6 January 2025

95

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Autophagy in metazoans: cell survival in the land of plenty

6 January 2025

96

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients

6 January 2025

97

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning.

6 January 2025

98

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

FoxO3 controls autophagy in skeletal muscle in vivo

6 January 2025

100

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia

6 January 2025

101

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Exercise training attenuates the hypermuscular phenotype and restores skeletal muscle function in the myostatin null mouse

6 January 2025

102

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer

6 January 2025

103

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase alpha1 following overload in LKB1 knockout mice.

6 January 2025

104

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1beta in skeletal muscle

6 January 2025

105

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The fine structure of type II muscle fiber atrophy

6 January 2025

106

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

S6 kinase inactivation impairs growth and translational target phosphorylation in muscle cells maintaining proper regulation of protein turnover

6 January 2025

107

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.

6 January 2025

108

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Differential gene expression in a murine model of cancer cachexia

6 January 2025

109

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia

6 January 2025

110

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes

6 January 2025

111

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs

6 January 2025

113

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling.

6 January 2025

114

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients

6 January 2025

115

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Tumors secreting human TNF/cachectin induce cachexia in mice

6 January 2025

116

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification

6 January 2025

117

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients

6 January 2025

118

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity.

6 January 2025

119

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Fibrinogen Synthesis Is Elevated in Fasting Cancer Patients with an Acute Phase Response

6 January 2025

120

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy

6 January 2025

121

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states?

6 January 2025

122

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Glucocorticoid blockade does not abrogate tumor-induced cachexia

6 January 2025

123

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Targeting protein synthesis in a Myc/mTOR-driven model of anorexia-cachexia syndrome delays its onset and prolongs survival

6 January 2025

124

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

6 January 2025

125

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory

6 January 2025

126

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate.

6 January 2025

127

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Fat loss in cachexia--is there a role for adipocyte lipolysis?

6 January 2025

128

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Lipolysis--not inflammation, cell death, or lipogenesis--is involved in adipose tissue loss in cancer cachexia

6 January 2025

129

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Lipid-induced insulin resistance: unravelling the mechanism

6 January 2025

130

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice

6 January 2025

131

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

6 January 2025

132

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription

6 January 2025

133

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Smad2 and 3 transcription factors control muscle mass in adulthood.

6 January 2025

134

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Myostatin mutation associated with gross muscle hypertrophy in a child

6 January 2025

135

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The relationship between weight loss and interleukin 6 in non-small-cell lung cancer

6 January 2025

136

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The SCF-Fbxo40 Complex Induces IRS1 Ubiquitination in Skeletal Muscle, Limiting IGF1 Signaling

6 January 2025

137

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Serum levels of interleukin-10 and interleukin-12 in patients with colorectal cancer

6 January 2025

138

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Insulin-like growth factor I in skeletal muscle after weight-lifting exercise in frail elders

6 January 2025

139

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Tumor necrosis factor alpha (TNF-α) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubes

6 January 2025

140

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer.

6 January 2025

141

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Adipokines in patients with cancer anorexia and cachexia.

6 January 2025

142

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia

6 January 2025

143

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Calpain activity is increased in skeletal muscle from gastric cancer patients with no or minimal weight loss

6 January 2025

144

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Intramyocellular lipid droplets increase with progression of cachexia in cancer patients

6 January 2025

146

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

6 January 2025

147

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

6 January 2025

148

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo

6 January 2025

149

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Interleukin-10 gene polymorphisms influence susceptibility to cachexia in patients with low-third gastric cancer in a Chinese population.

6 January 2025

150

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS.

6 January 2025

151

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Cytokine gene polymorphisms and susceptibility to cachexia

6 January 2025

152

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

6 January 2025

153

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

P-selectin genotype is associated with the development of cancer cachexia

6 January 2025

154

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Identification of a human tumor-derived lipolysis-promoting factor

6 January 2025

155

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats

6 January 2025

156

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

A Single Nucleotide Polymorphism in NF-κB Inducing Kinase Is Associated with Mortality in Septic Shock

6 January 2025

157

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

6 January 2025

Cancer cachexia

158

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361).

6 January 2025

159

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size

6 January 2025

160

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A

6 January 2025

161

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Cold-activated brown adipose tissue in healthy men

6 January 2025

162

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Functional brown adipose tissue in healthy adults

6 January 2025

163

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy

6 January 2025

164

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Muscle growth after postdevelopmental myostatin gene knockout

6 January 2025

165

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse

6 January 2025

166

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Inhibition of myostatin in adult mice increases skeletal muscle mass and strength

6 January 2025

167

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Is there a human homologue to the murine proteolysis-inducing factor?

6 January 2025

168

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6

6 January 2025

169

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor

6 January 2025

171

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

FBXO40, a gene encoding a novel muscle-specific F-box protein, is upregulated in denervation-related muscle atrophy

6 January 2025

173

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Inhibition of IRS-1 phosphorylation and the alterations of GLUT4 in isolated adipocytes from cachectic tumor-bearing rats

6 January 2025

174

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure

6 January 2025

175

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

FAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling

6 January 2025

176

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting

6 January 2025

177

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells

6 January 2025

178

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival

6 January 2025

179

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase

6 January 2025

180

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Induction of cachexia in mice by systemically administered myostatin.

6 January 2025

181

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects

6 January 2025

182

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011

Metabolic response to enteral food in different phases of cancer cachexia in rats

6 January 2025

183

1 reference

https://api.crossref.org/works/10.1016/J.CMET.2012.06.011